Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes. Hannelius U, Beam CA, Ludvigsson J. Diabetologia 2020 Aug 5. pii: 10.1007/s00125-020-05227.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hannelius U, Beam CA, Ludvigsson J. Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes. Diabetologia 2020 Aug 5. pii: 10.1007/s00125-020-05227.
PMID: 32754804